EPISODE · Dec 14, 2021 · 11 MIN
Risk of Breast Cancer With Prolactin Elevating Antipsychotic Drugs
from The Journal of Clinical Psychopharmacology Podcast
A large observational study from researchers at Washington University in St. Louis found an elevated risk of breast cancer in women who take some types of antipsychotic drugs – specifically, drugs that raise levels of the hormone prolactin. In this podcast, Dr. Tahir Rahman, lead author of the study, discusses the findings and their implications for patient care.
NOW PLAYING
Risk of Breast Cancer With Prolactin Elevating Antipsychotic Drugs
0:00
11:40
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of The Journal of Clinical Psychopharmacology Podcast?
This episode is 11 minutes long.
When was this The Journal of Clinical Psychopharmacology Podcast episode published?
This episode was published on December 14, 2021.
What is this episode about?
A large observational study from researchers at Washington University in St. Louis found an elevated risk of breast cancer in women who take some types of antipsychotic drugs – specifically, drugs that raise levels of the hormone prolactin. In this...
Can I download this The Journal of Clinical Psychopharmacology Podcast episode?
Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!